← Cigna Group
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $39.8b | $41.8b | $48.6b | $153.6b | $160.4b | $174.1b | $180.5b | $195.3b | $247.1b | $274.9b | |
| Revenues: | |||||||||||
| Cost of Revenue | $36.8b | $2.5b | $4.8b | $97.7b | $103.5b | $117.6b | $124.8b | $133.8b | $182.5b | $215.0b | |
| Gross Profit (Calculated) | $3.1b | $39.4b | $43.9b | $55.9b | $56.9b | $56.5b | $55.7b | $61.5b | $64.6b | $59.9b | |
| Operating Income (Loss) | $3.1b | $3.9b | $4.2b | $8.1b | $8.2b | $7.9b | $8.4b | $8.5b | $9.4b | $9.2b | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $151.0m | $115.0m | $235.0m | $2.9b | $2.0b | $2.0b | $1.9b | $1.8b | $1.7b | $1.7b | |
| Amortization of acquired intangible assets | $151.0m | $115.0m | $235.0m | $2.9b | $2.0b | $2.0b | $1.9b | $1.8b | $1.7b | $1.7b | |
| Debt extinguishment gain | $0 | ($321.0m) | $0 | ($2.0m) | ($199.0m) | ($141.0m) | $0 | $0 | — | — | |
| Net gain (loss) on sale of businesses | — | — | $0 | $0 | $4.2b | $0 | $1.7b | ($1.5b) | $24.0m | $13.0m | |
| Net investment losses | — | — | — | — | — | — | ($487.0m) | ($78.0m) | ($2.7b) | ($24.0m) | |
| Premiums | $30.8b | $32.5b | $36.1b | $39.7b | $42.6b | $41.2b | $39.9b | $44.2b | $46.0b | $40.3b | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $3.0b | $3.6b | $3.6b | $6.6b | $10.9b | $6.8b | $8.4b | $5.5b | $5.3b | $7.8b | |
| Net Investment Income | $1.1b | $1.2b | $1.5b | $1.4b | $1.2b | $1.5b | $1.2b | $1.2b | $973.0m | $1.0b | |
| Policyholder Benefits and Claims Incurred, Net | $24.3b | $25.3b | $27.5b | $30.8b | $32.7b | $33.6b | $32.2b | $36.3b | $38.6b | $34.3b | |
| Premiums Earned, Net | $30.8b | $32.5b | $36.1b | $39.7b | $42.6b | $41.2b | $39.9b | $44.2b | $46.0b | $40.3b | |
| TOTAL INCOME TAXES | $1.1b | $1.4b | $935.0m | $1.4b | $2.4b | $1.4b | $1.6b | $141.0m | $1.5b | $1.5b | |
| Income before income taxes | $3.0b | $3.6b | $3.6b | $6.6b | $10.9b | $6.8b | $8.4b | $5.5b | $5.3b | $7.8b | |
| SHAREHOLDERS' NET INCOME | $1.9b | $2.2b | $2.6b | $5.1b | $8.5b | $5.4b | $6.7b | $5.2b | $3.4b | $6.0b | |
| Net Income (Loss) Attributable to Parent | $1.8b | $2.2b | $2.6b | $5.1b | $8.5b | $5.4b | $6.7b | $5.4b | $3.8b | $6.0b | |
| Net Income (Loss) Available to Common Stockholders, Basic | $1.8b | $2.2b | $2.6b | $5.1b | $8.5b | $5.4b | $6.7b | $5.2b | $3.4b | $6.3b | |
| Less: Net income attributable to noncontrolling interests | ($24.0m) | ($5.0m) | $9.0m | $16.0m | $31.0m | $50.0m | $78.0m | $208.0m | $344.0m | $331.0m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | ($24.0m) | ($5.0m) | $9.0m | $16.0m | $31.0m | $50.0m | $78.0m | $208.0m | $344.0m | $331.0m | |
| Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest | — | ($5.0m) | $0 | $5.0m | $17.0m | $31.0m | $67.0m | $28.0m | $344.0m | $331.0m | |
| Common Stock, Dividends, Per Share, Declared | $7.31 | $8.92 | $10.69 | $0.04 | $0.04 | $4.00 | $4.48 | $4.92 | $5.60 | $6.04 | |
| Earnings Per Share, Basic | $7.31 | $8.92 | $10.69 | $13.58 | $23.17 | $15.87 | $21.54 | $17.57 | $12.25 | $22.33 | |
| Earnings Per Share, Diluted | $7.19 | $8.77 | $10.54 | $13.44 | $22.96 | $15.73 | $21.30 | $17.39 | $12.12 | $22.18 | |
| Weighted Average Number of Shares Outstanding, Diluted | — | 255.1m | 250.2m | 379.8m | 368.4m | 341.0m | 313.1m | 296.9m | 283.2m | 268.6m | |
| Expenses | |||||||||||
| Current Income Tax Expense (Benefit) | — | $1.1b | $1.0b | $1.8b | $2.8b | $1.6b | $2.1b | $1.8b | $1.6b | $1.2b | |
| Deferred Policy Acquisition Costs, Amortization Expense | — | $322.0m | $406.0m | $483.0m | $502.0m | $478.0m | $319.0m | — | — | — | |
| Interest Expense, Debt | — | $243.0m | $507.0m | $1.6b | $1.4b | $1.3b | $1.3b | $1.4b | $1.5b | $1.4b | |
| Interest expense and other | ($278.0m) | ($252.0m) | ($498.0m) | ($1.7b) | ($1.4b) | ($1.2b) | ($1.2b) | ($1.4b) | ($1.4b) | ($1.4b) | |
| Medical costs and other benefit expenses | $24.3b | $25.3b | $27.5b | $30.8b | $32.7b | $33.6b | $32.2b | $36.3b | $38.6b | $34.3b | |
| Other Nonoperating Income (Expense) | ($278.0m) | ($252.0m) | ($498.0m) | ($1.7b) | ($1.4b) | ($1.2b) | ($1.2b) | ($1.4b) | ($1.4b) | ($1.4b) | |
| Pharmacy and other service costs | $2.5b | $2.5b | $4.8b | $97.7b | $103.5b | $117.6b | $124.8b | $133.8b | $182.5b | $215.0b | |
| Selling, General and Administrative Expense | $9.8b | $10.0b | $11.9b | $14.1b | $14.1b | $13.0b | $13.2b | $14.8b | $14.8b | $14.6b | |
| Selling, general and administrative expenses | $9.8b | $10.0b | $11.9b | $14.1b | $14.1b | $13.0b | $13.2b | $14.8b | $14.8b | $14.6b | |
| Benefits, Losses and Expenses | $36.8b | $37.9b | $44.5b | $145.5b | $152.2b | $166.1b | $172.1b | $186.7b | $237.7b | $265.7b | |
| Income Tax Expense (Benefit) | $1.1b | $1.4b | $935.0m | $1.4b | $2.4b | $1.4b | $1.6b | $141.0m | $1.5b | $1.5b | |
| TOTAL BENEFITS AND EXPENSES | $36.8b | $37.9b | $44.5b | $145.5b | $152.2b | $166.1b | $172.1b | $186.7b | $237.7b | $265.7b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.